10.1007/s00259-016-3533-z - Long-term follow-up and role of FDG P...

This document has been corrected

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

10.1007/s00259-016-3533-z

Published Online: 2016-10-04

Journal: European Journal of Nuclear Medicine and Molecular Imaging•Publisher: Springer Science and Business Media LLC

Authors: Alberto Bongiovanni•Annarita Ianniello•Chiara Maria Grana•Emanuela Scarpi•Emilio Mezzenga•Fabio Ferroni•Giovanni Paganelli•Lisa Bodei•Lorenzo Fantini•Maddalena Sansovini•Manuela Monti•Sara Cingarlini•Silvia Nicolini•Stefano Severi

This document has been corrected

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

10.1007/s00259-016-3533-z

Published Online: 2016-10-04

Journal: European Journal of Nuclear Medicine and Molecular Imaging

NOW

2016-11-02•Erratum

Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

10.1007/s00259-016-3558-3

* information provided by CrossRef

2016-11-02•Erratum

10.1007/s00259-016-3558-3

* information provided by CrossRef

2016-10-04•Published

2016-11-02•Erratum

Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

10.1007/s00259-016-3558-3

* information provided by CrossRef

This document has been corrected

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

10.1007/s00259-016-3533-z

Published Online: 2016-10-04

Journal: European Journal of Nuclear Medicine and Molecular Imaging•Publisher: Springer Science and Business Media LLC